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Abstract
Background: Sleep disordered breathing occurs in over half of
the estimated 5.1 million people in the United States diagnosed
with heart failure.

the Berlin questionnaire. Using one of these tools along with
an overnight pulse oximetry is a cost effective way to screen
patients before the more costly sleep studies.

Aim and Methods: The purpose of this integrative review is
to find evidence for the routine use of a sleep apnea screening
protocol in patients with heart failure.

Conclusions: Evidence shows that treatment of sleep apnea
in this population decreases not only morbidity and mortality
rates, but the overall cost burden of the disease as well.

Results: Several useful tools are described including the
Epworth Sleepiness Scale, the STOP BANG questionnaire and

Keywords: sleep apnea, screening tools, heart failure

How this fits with quality in primary care
What do we know?
Heart failure patients are at risk for sleep apnea. This sleep disordered breathing may affect their survival and quality of life.
Sleep studies are ordered as needed, but can be expensive.
What does this paper add
Describes the types of sleep apnea, the variety of screening tools for sleep apnea and provides evidence for advising providers
to screen all patients with heart failure for sleep apnea with both a screening tool and pulse oximetry before ordering the gold
standard sleep study.

Introduction
According to the Centers for Disease Control (CDC)
approximately 5.1 million people in the United States have a
diagnosis of heart failure and half will die within five years of
diagnosis.1 Heart failure is characterized by its high mortality,
frequent hospitalizations and a reduced quality of life with
estimates of costs to the nation reach $37 billion each year.2 There
is accumulating evidence that nocturnal breathing disorders are
important modifiers of disease progression in patients with heart
failure. Sleep-disordered breathing, or sleep apnea is the most
common comorbidity in heart failure patients, occurring in over
half of heart failure patients and can exacerbate the illness.3,4

Review of the Literature
A review of the literature using the keywords heart failure,
sleep apnea, treatment, and screening in the CINAHL and
PubMed databases was completed. Research studies that
evaluated apnea screening and/or treatment were reviewed.
Three major treatment modalities and three screening tools
emerged for both types of sleep-disordered breathing.
Sleep apnea is defined as a combination of hypopnea (slow,
shallow breathing for 10 seconds or more) and apnea (cessation
of breathing for 10 seconds or more) that results in a decrease
in blood oxygen saturation.5 Improving morbidity and mortality

in heart failure patients involves assessing factors such as sleep
disordered breathing that impact the progression of the disease.
Several types of sleep-disordered breathing have been identified
in the heart failure population including obstructive sleep apnea,
central sleep apnea, and complex sleep apnea syndrome. 6,4

Types of Sleep Apnea
Obstructive sleep apnea affects approximately 35% of heart
failure patients and is caused by partial or complete collapse or
obstruction of the upper airway.4 It causes a change in intrathoracic pressure and an increased sympathetic drive resulting in
a cascade of physiological changes including decreased cardiac
output, increased myocardial oxygen demand, vasoconstriction,
hypertension, and activation of the renal renin-angiotensin
system.
Central sleep apnea is more complex and difficult to treat,
as its cause is the temporary withdrawal of the brainstemdriven respiratory drive.4 A distinct pattern of Cheyne-Stokes
respiration is present in central apnea or hypopnea followed
by hyperventilation in a cyclic crescendo-decrescendo pattern
resulting in an oscillation of arterial carbon dioxide above and
below the threshold for apnea.
Complex sleep apnea involves repeated episodes of central
apnea during treatment with CPAP in patients who initially
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present with obstructive apnea. It is more difficult to treat
and may need a higher level of ventilator support than CPAP
such as adaptive sero-ventilation.7 Identification of the type of
sleep apnea and treatment in heart failure patients is critical to
improving the outcomes. 8
Continuous Positive Airway Pressure (CPAP)- The effects
of CPAP is a continuous, low-level end-expiratory pressure to
helps maintain an open airway as treatment for sleep-disordered
breathing. A meta-analysis determined that CPAP improves
left ventricular function (LVEF) in those patients with both
obstructive sleep apnea and documented heart failure.9
Bi-level Positive Airway Pressure (BiPAP) -The benefit
of this therapy is that it adds additional respiratory support to
the existing CPAP adding a set level of inspiratory pressure
administered with each breath. Khayat et al. (2008) compared
the use of CPAP in treatment of obstructive sleep apnea to the
use of BiPAP in improving stable systolic dysfunction heart
failure patients and found it to be superior to CPAP in increasing
left ventricular function.13
Adaptive
Servoventilation
(ASV)
-Adaptive
servoventilation (dynamic BiPAP) adjusts the inspiratory
support component according to the needs of the patient.
Although CPAP has been shown to improve cardiac function in
heart failure patients with sleep apnea, it has been unsuccessful
in suppressing central sleep apnea in nearly 50% of treated
patients.14 Research supports the use of ASV for the suppression
of central sleep apneas as well as mixed apneas in the heart
failure patient. Arzt et al. (2008) studied heart failure patients
with central and complex sleep apneas and, ASV was found to
have the greatest reduction in the apnea (Table 1).17

Screening Tools
Several screening tools have been designed to identify sleep
apnea in a variety of populations. A review of the literature with
specific emphasis on diagnosing sleep apnea in the heart failure
population revealed three tools most commonly used: the
Epworth Sleepiness Scale, the STOP-Bang Equivalent Model,
and the Berlin Questionnaire (Appendices 1-3).
1. Epworth Sleepiness Scale (ESS) A review by Rosenthal

& Dolan (2008) to assess the sensitivity of the ESS in identifying
obstructive sleep apnea was conducted on patients screened
with the tool with a subsequent sleep study.18 Epworth scores
were analyzed in comparison to apnea index greater than or
equal to five and it was determined that the screening tool alone
had a fair discriminatory ability as a screener for obstructive
sleep apnea.
2. The STOP-Bang model was considered the simplest
to use and score. A systematic review of obstructive sleep
apnea screening questionnaires by reviewed 10 studies aimed
at screening for SDB concluded that such screening tools
are associated with promising results.19 Farney et al. (2011)
conducted a study using the STOP-Bang Equivalent model
(SBM) and its ability to predict obstructive sleep apnea in
comparison to the sleep study to further classify obstructive
sleep apnea into categories ranging from none to severe.20 With
STOP-Bang scores of 6-8 there was a high probability of being
diagnosed with obstructive sleep apnea via sleep study.
3. The Berlin Questionnaire (BQ) sleep apnea screening
tool was evaluated as to its sensitivity and specificity compared
to the gold standard PSG sleep study as a diagnostic tool. A
retrospective review of 130 sleep-clinic patients to determine
its effectiveness found the BQ to have moderate specificity and
low sensitivity in correctly diagnosing sleep apnea.21 A metaanalysis of multiple screening tests for obstructive sleep apnea
found the Berlin Questionnaire to be one of the most accurate
questionnaires.22
Combining both a sleep-screening tool and overnight
pulse oximetry has proven useful. Garner & Traverse (2014)
implemented an evidence-based protocol to screen for sleep apnea
in a heart failure disease management clinic.23 Utilizing a screening
tool, and overnight pulse oximetry test was clinically beneficial and
cost effective in this population. Another study found significantly
favorable results in diagnosing apnea after confirmation by sleep
study, in their patient population when compared to using the
screening tool alone.23 It was noted however, a high number of false
negatives were found with all screens, including the BQ with the
least accurate screen thought to be the ESS due to the plethora of
other causative factors for daytime sleepiness.21,22

Table 1: Types of Respiratory Support for Sleep Apnea.
Treatment Type

Mechanism
A continuous, low-level endexpiratory pressure that helps
Continuous Positive Airway
maintain an open airway as
Pressure (CPAP)
treatment for sleep-disordered
breathing. Sun et al. 2013
Adds additional respiratory
support to the existing CPAP
Bi Level Positive Airway Pressure
adding a set level of inspiratory
(BiPAP)
pressure administered with each
breath. Khayat et al. (2008)
Adaptive Servoventilation (ASV)

Benefits described in research
Improved overall health9
Reduced risk of hospitalizations & death10, 11
Improved left ventricular function & cardiac efficiency9,12
Heart transplant free survival Arzt12
Improves stable systolic dysfunction heart failure
patients13
Superior to CPAP in increasing left ventricular function13

Improves cardiac function in heart failure patients with
Adjusts the inspiratory support
sleep apnea. Suppresses central sleep apnea and complex
component according to the needs
mixed apneas14,15
of the patient.
Improved exercise tolerance14
(Sharma et al., 2012).
Positive effect on renal function16
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Synthesis of the Evidence
This review supports the need for screening, diagnosis,
and treatment of sleep-disordered breathing in the heart failure
population. Untreated severe sleep disordered breathing has
been found to have a statistically significant increased risk of
all cause mortality. 24 Although using an overnight sleep study
in a sleep lab is considered the gold standard for diagnosis of
sleep-disordered breathing, such a study can be time-consuming
and costly.
Evidence-based screening tools such as The Epworth
Sleepiness Scale (ESS) (Appendix 2), which measure subjective
daytime sleepiness, or The STOP-Bang Questionnaire
(Appendix 3), which assesses risk factors for obstructive sleep
apnea, should be used to screen those at highest risk for sleepdisordered breathing in the heart failure population. Despite the
research consensus that such screens have inconsistencies and
a high rate of false-positive results, when used in conjunction
with a secondary screen of higher sensitivity and specificity
such as overnight oximetry identification of patients with a
true diagnosis of sleep apnea becomes more likely.18,20,21&25
These patients could then be referred for a formal sleep study
if needed to confirm or refute sleep apnea based on a positive,
multi-leveled screen.
Healthcare insurance companies are more likely to cover
the cost of sleep studies in the presence of an oximetry study
indicative of periods of hypoxia. Later confirmation of suspected
diagnosis through PSG, the gold standard, has proven this
screening protocol to be an effective method for identifying and
diagnosing sleep apnea in the heart failure population.23 Once
the long-term goal of complete protocol screening has been
implemented and treatment instituted, long-term compliance
with sleep apnea treatment can be reinforced by noting the
patients verbalization of improved symptoms, improved
screening scores, or by means of repeat echocardiogram
(ECHO) which could possibly show documented improvement
of heart function.
Garner & Traverse (2013) studied the health behaviors and
sleep apnea treatment adherence in the heart failure patient and
found that non-compliance was highest in the elderly and in
women for various reasons such as the prospect of an overnight
sleep study outside of the home, being “too old” for evaluation
and treatment, complications with other diagnoses, and cost.27
For those who underwent PSG evaluation; but did not comply
with the recommended CPAP treatment, common reasons
given were mask intolerance, claustrophobia, and drying of
the nose.27 Ongoing disease education plays a large factor in
addressing not only the modifiable risk factors for heart failure
as a disease. The resulting compliance to treatment greatly
impacts quality of life, heart failure disease progression, and
ultimately morbidity and mortality.28

Discussion and Conclusion
The implementation and use an evidence-based sleep apnea
screening tool, in conjunction with overnight pulse oximetry
studies for those who are scored as high risk helps screen at risk
patients before the more expensive sleep study and diagnosis
of a sleep disordered breathing condition. Sleep apnea in the

heart failure population should be approached as a co-existing
chronic disease requiring long-term management.
The American Heart Association guidelines state that
“Continuous positive airway pressure can be beneficial to
increase LVEF and improve functional status in patients with
heart failure and sleep apnea” 30
Unfortunately, sleep apnea is not part of the routine evaluation
and management of heart failure, so it remains untreated in
most patients. Medical providers can play an instrumental role
in screening and identifying those patients at highest risk for
sleep apnea using an evidence-based screening protocol. Once
identified and diagnosed, providers can reinforce the need for
disease management and construct an individualized educational
plan to increase adherence with recommended therapies.
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